IMPAX Laboratories to Hold Fourth Quarter & Year-End 2002 Financial Results Conference Call Wednesday, February 12, 2003

February 05, 2003

Feb. 5, 2003--IMPAX Laboratories Inc. (Nasdaq:IPXL) today announced that the Company will release 2002 fourth quarter and year-end financial results on Wednesday, February 12, 2003.

Barry Edwards, Co-Chief Executive Officer, and Cornel C. Spiegler, Chief Financial Officer, will host an investment conference call beginning at 2:00 p.m. Eastern Time (11 a.m. Pacific Time) to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (888) 803-7396 from the U.S., or for international callers, please dial (706) 634-1052.

Those interested in listening to the conference call live via the Internet may do so by visiting the Company's Web site at To listen to the live call, please go to the Website 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the Company Web site for 14 days. A telephone replay will be available for 48 hours by dialing (800) 642-1687 from the U.S., or (706) 645-9291 for international callers, and entering reservation 8341348.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: